A Study of BMS986365 in Combination With Degarelix in People with Prostate Cancer

Full Title

A Phase 2 Study of Androgen Deprivation Therapy and BMS986365 in High-Risk Localized Prostate Cancer Patients Prior to Radical Prostatectomy

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Kristine Lacuna’s office at 646-888-4321.

Protocol

25-262

Phase

Phase II (phase 2)

Co-Investigators

ClinicalTrials.gov ID

NCT07335796